EXHIBIT 10.10 RESEARCH COLLABORATION AND LICENSING AGREEMENT BETWEEN GEORGETOWN UNIVERSITY AND SAMARITAN PHARMACEUTICALS, INC.Research Collaboration and Licensing Agreement • July 31st, 2003 • Samaritan Pharmaceuticals Inc • Services-commercial physical & biological research • District of Columbia
RESEARCH COLLABORATION AND LICENSING AGREEMENT AMONG The RESEARCH INSTITUTE of MCGILL UNIVERSITY HEALTH CENTER AND SAMARITAN PHARMACEUTICALS, INC. AND SAMARITAN THERAPEUTICSResearch Collaboration and Licensing Agreement • July 25th, 2007 • Samaritan Pharmaceuticals Inc • Services-commercial physical & biological research • Quebec
This RESEARCH COLLABORATION AND LICENSING AGREEMENT (“Agreement”), is entered into as of , by and between the Research Institute of McGill University Health Center (“RI-MUHC”), a research and educational institution located at and Samaritan Pharmaceuticals, Inc. (“Samaritan”), a for-profit corporation organized under the laws of the State of Nevada, with its principal place of business at and Samaritan Therapeutics (“Therapeutics”), a Canadian corporation located at (Collectively “Parties”).
Genentech, startup sign $330 mn deal for cancer targetsResearch Collaboration and Licensing Agreement • September 14th, 2021
